Tech Company Financing Transactions

Trace Neuroscience Funding Round

Third Rock Ventures, Atlas Venture and GV participated in a $101 million Series A capital raise for Trace Neuroscience. The round was announced on 11/12/2024.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

750 Gateway Blvd 200
San Francisco, CA 94080
USA

Phone

Undisclosed

Website

www.traceneuro.com

Email Address

[email protected]

Overview

ALS, or amyotrophic lateral sclerosis, is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. In the U.S., approximately 30,000 people are living with ALS, and 1 in 400 people around the world will be diagnosed with this debilitating and devastating disease during their lifetime.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Eric Green

        

Browse more venture capital transactions:

Prev: 11/12/2024: MintNeuro venture capital transaction
Next: 11/12/2024: Salesfire venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on every notable VC transaction. VC transactions on this site are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary